Ashwagandha Gains Traction as Interest in Adaptogens Grows
Consumer interest in the adaptogen ashwagandha is surging, driven by its perceived benefits for stress relief and sleep. The market is projected to reach $16.3 billion by 2030, with food and beverage companies increasingly incorporating standardized extracts into functional products.
Why it matters
This reflects a broader shift in the wellness industry toward functional ingredients and evidence-based herbal supplements in mainstream consumer goods.
Growing consumer interest in adaptogens is driving demand for ashwagandha, a botanical ingredient associated with stress relief, sleep support, and functional food and beverage innovation.
Consumers are showing growing interest in adaptogens, the natural, nontoxic plants traditionally used to help the body adapt to physical, mental, and emotional stress. The global adaptogens market size was estimated at approximately $10.9 billion in 2024 and is projected to reach $16.3 billion by 2030, according to Grand View Research.
Among these ingredients, ashwagandha has emerged as one of the most widely used, noted particularly for its associations with stress management and sleep support. In the United States, ashwagandha was the third-most-purchased herbal supplement in 2024, with sales totaling $144 million, according to the American Botanical Council.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in